NEPHROGENEX INC's ticker is NRXGQ and the CUSIP is 640667101. A total of 14 filers reported holding NEPHROGENEX INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $1,000 | -66.7% | 2,000 | 0.0% | 0.00% | – |
| Q4 2015 | $3,000 | -92.1% | 2,000 | -82.0% | 0.00% | – |
| Q3 2015 | $38,000 | -36.7% | 11,100 | +22.0% | 0.00% | – |
| Q2 2015 | $60,000 | -16.7% | 9,100 | 0.0% | 0.00% | – |
| Q1 2015 | $72,000 | -40.5% | 9,100 | 0.0% | 0.00% | – |
| Q4 2014 | $121,000 | +181.4% | 9,100 | 0.0% | 0.00% | – |
| Q3 2014 | $43,000 | -82.0% | 9,100 | -76.8% | 0.00% | – |
| Q2 2014 | $239,000 | -25.1% | 39,300 | 0.0% | 0.00% | – |
| Q1 2014 | $319,000 | – | 39,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,326,826 | $6,210,000 | 3.12% |
| Knoll Capital Management, LLC | 50,000 | $234,000 | 0.09% |
| FIRST NEW YORK SECURITIES LLC /NY | 24,314 | $113,790,000 | 0.08% |
| LMR Partners LLP | 147,250 | $689,000 | 0.06% |
| Visium Asset Management, LP | 477,000 | $2,232,000 | 0.03% |
| First Western Capital Management Co | 13,100 | $61,000 | 0.02% |
| STONERIDGE INVESTMENT PARTNERS LLC | 19,125 | $90,000 | 0.01% |
| Ground Swell Capital, LLC | 756 | $4,000 | 0.01% |
| UBS AG | 1,466 | $7,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 9,100 | $43,000 | 0.00% |